APEIRON is a focused on the discovery and development of novel cancer immunotherapies. APEIRON’s lead clinical program APN401 is a first-in-class autologous cellular therapy to enhanc immune reactivity via an intracellular immune master checkpoint, Cbl-b. APEIRON’s key projects and technologies are bolstered by a strong patent portfolio with broad territorial coverage. APEIRON’s development expertise is validated through partnerships with leading global pharmaceutical companies and academic institutions.

In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. At Takeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer. They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.

Biomimetics Sympathies is a bio technical firm that research on the medicine and create products and regenerative medicine.

SystImmune is a biopharmaceutical company. It is focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug conjugates. They are highly experienced immuno-oncology scientists utilizing several technology platforms to develop world-class advanced antibody-based drug therapies.

Pinetree Therapeutics, Inc. is a biotherapeutics company which engages in the development of antibodies to treat cancer. The company was founded by Ho-Juhn Song and is headquartered in Cambridge, MA.

Chengdu Wesker Biopharmaceutical Co., Ltd., established on 2020-07-14, Business scope includes licensed projects:Drug import and export;Technology Import and Export;Import and export;pharmaceutical production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the sale of gastrointestinal drugs such as Seirogan, Seirogan Toui A, and Seirogan Quick C. The Infection Control segment offers hygiene products such as Cleverin and clev&and. The Others segment provides vinegar-related products. The company was founded by Otojiro Shibata in July 1940 and is headquartered in Osaka, Japan.

Yi Shi Bio is a joint venture and a leading IVD solution provider. With manufacturing facilities in Beijing, Nantong, and Wuxi, Yi Shi Bio develop, produce, and distribute diagnostic kits all over the world. Their products include Rapid Tests, Elisa kits, CLIA and POCT analyzer systems, and they have registered the trade mark EGENS. To date, EGENS has received certification for its quality management systems (QMS) under the following standards: ISO9001, ISO13485 CMDR, ISO14001, OSHAS18001, and GMP.

Sichuan Xia Paisen Pharmaceutical Technology Co., Ltd., established on 2016-05-26, Business scope includes drug research and development and technical services,technology transfer,technical consulting;Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

KNC Laboratories Co., Ltd. engages in research, development, and production solutions for organic chemicals. Its operations are carried out through the following business divisions: Functional Chemicals and Drugs. The Functional Chemicals division provides the broad and consistent support services from basic basic research to OEM (Original Equipment Manufacturer) production. The Drugs division provides the consistent support in every phase of medicine research & development, and production. The company was founded on January 22, 1985 and is headquartered in Kobe, Japan.

Sichuan Baili Pharmaceutical Co., Ltd., established on 1996-08-23, Business scope includes licensed projects:pharmaceutical production;Health food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Import and export;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Healthy food(prepackaged)Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Mvrix Co. Ltd. is a company headquartered in the South Korea that develops infectious disease treatments.

Shanghai Kalulan Technology Co., Ltd., established on 2012-09-18, Business scope includes engaging in biotechnology,chemical technology,Technology development in the field of computer technology,Technical Services,technical consulting,technology transfer,Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Norimun AS develops IgY antibodies for passive immunization in aquaculture and livestock markets. The company is headquartered in Akershus, Norway.

The Korea Institute of Ocean Science and Technology (KIOST) with its headquarters in Busan, South Korea, has driven development of the marine sciences and technology of Korea for almost 50 years since its establishment in 1973. Formerly known as the Korean Ocean Research and Development Institute (KORDI), it started functioning with the new name of Korea Institute of Ocean Science and Technology from July 1, 2012.

Order-made Medical Research is a biotech company promoting technology development that revolutionize therapeutic antibodies.We have made it possible to generate prominent antibodies against multi-transmembrane target molecules that have been difficult to create and have succeeded in expanding the number of target molecules extremely for therapeutic antibodies. Furthermore, as a further application development, we are challenging to create innovative therapeutic antibodies targeted intracellular molecules and disease-specific immunogenicity changes that have been difficult to target antibodies.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.